Placeholder image of a protein
Icon representing a puzzle

2579: HIKESHI Round 1

Closed since about 1 year ago

Intermediate Overall Small Molecule Design

Summary


Created
February 28, 2025
Expires
Max points
100
Description

HIKESHI Associated Leukodystrophy (HAL), also known as Hypomyelinating Leukodystrophy-13 (HLD13), is a devastating neurodegenerative disease that affects young children. Caused by specific mutations in the Hikeshi protein, HAL leads to severe neurological problems such as developmental delays, muscle stiffness (spasticity), and a smaller-than-normal head size (microcephaly). Tragically, children with HAL often experience a rapid decline or even death after a fever.

Scientists believe that these mutations make Hikeshi unstable, causing it to misfold. But there's hope! Just as small molecules have been used to help stabilize misfolded proteins in other diseases—like cystic fibrosis—we want to find molecules that could do the same for Hikeshi.

In this puzzle series, you'll start with a candidate molecule placed in a potential binding pocket on Hikeshi. Your challenge is to tweak and optimize this molecule to help stabilize the protein's structure. By using your skills, you could contribute to the discovery of a treatment for HAL and related neurodegenerative disorders.

Top groups


  1. Avatar for Marvin's bunch 11. Marvin's bunch 1 pt. 8,017
  2. Avatar for SETI.Germany 12. SETI.Germany 1 pt. 7,188
  3. Avatar for Foldit Staff 13. Foldit Staff 1 pt. 6,118

  1. Avatar for Th1sN@me!sN0tAPun 11. Th1sN@me!sN0tAPun Lv 1 49 pts. 15,150
  2. Avatar for alcor29 12. alcor29 Lv 1 46 pts. 15,050
  3. Avatar for TheGUmmer 13. TheGUmmer Lv 1 42 pts. 14,769
  4. Avatar for Hellcat6 14. Hellcat6 Lv 1 39 pts. 14,713
  5. Avatar for rinze 15. rinze Lv 1 36 pts. 13,714
  6. Avatar for NinjaGreg 16. NinjaGreg Lv 1 33 pts. 13,584
  7. Avatar for Mohoernchen 17. Mohoernchen Lv 1 31 pts. 13,572
  8. Avatar for BilNeutron 19. BilNeutron Lv 1 26 pts. 13,295
  9. Avatar for AlphaFold2 20. AlphaFold2 Lv 1 24 pts. 13,221

Comments